REFERENCES

• LeuchterAF.CookIA.HamiltonSP.et alBiomarkers to predict antidepressant response.Curr Psychiatry Rep.20101255356220963521
   PubMed Web of Science ®Google Scholar
• KrishnanV.NestlerEJ.Linking molecules to mood: new insight into the biology of depression.Am J Psychiatry.20101671305132020843874
   PubMed Web of Science ®Google Scholar
• TantiA.BelzungC.Open questions in current models of antidepressant action.Br J Pharmacol.20101591187120020132212
   PubMed Web of Science ®Google Scholar
• NiciuMJ.MathewsDC.NugentAC.et alDeveloping biomarkers in mood disorders research through the use of rapid-acting antidepressants.Depress Anxiety.20143129730724353110
   PubMed Web of Science ®Google Scholar
• Meyer-LindenbergA.WeinbergerDR.Intermediate phenotypes and genetic mechanisms of psychiatric disorders.Nat Rev Neurosci.2006781882716988657
   PubMed Web of Science ®Google Scholar
• FornitoA.BullmoreET.Connectomic intermediate phenotypes for psychiatric disorders.Front Psychiatry.201233222529823
   PubMedGoogle Scholar
• InselTR.The NIMH Research Domain Criteria (RDoC) project: precision medicine for psychiatry.Am J Psychiatry.201417139539724687194
   PubMed Web of Science ®Google Scholar
• InselT.CuthbertB.GarveyM.et alResearch domain criteria (RDoC): toward a new classification framework for research on mental disorders.Am J Psychiatry.201016774875120595427
   PubMed Web of Science ®Google Scholar
• ShynSI.HamiltonSP.The genetics of major depression: moving beyond the monoamine hypothesis.Psychiatr Clin North Am.20103312514020159343
   PubMed Web of Science ®Google Scholar
• SanacoraG.TreccaniG.PopoliM.Towards a glutamate hypothesis of depression an emerging frontier of neuropsychopharmacology for mood disorders.Neuropharmacology.201262637721827775
   PubMed Web of Science ®Google Scholar
• SharpT.Molecular and cellular mechanisms of antidepressant action.Curr Top Behav Neurosci.20131430932522865463
   PubMedGoogle Scholar
• SullivanPF.NealeMC.KendlerKS.Genetic epidemiology of major depression: reviewand metaanalysis.Am J Psychiatry.20001571552156211007705
   PubMed Web of Science ®Google Scholar
• RipkeS.WrayNR.LewisCM.et alA mega-analysis of genomewide association studies for major depressive disorder.Mol Psychiatry.20131849751122472876
   PubMed Web of Science ®Google Scholar
• FlintJ.KendlerKS.The genetics of major depression.Neuron.20148148450324507187
   PubMed Web of Science ®Google Scholar
• KendlerKS.KuhnJ.PrescottCA.The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression.Am J Psychiatry.200416163163615056508
   PubMed Web of Science ®Google Scholar
• SilbergJ.RutterM.NealeM.EavesL.Genetic moderation of environmental risk for depression and anxiety in adolescent girls.Br J Psychiatry.200117911612111483472
   PubMed Web of Science ®Google Scholar
• RietschelM.MattheisenM.FrankJ.et alGenome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression.Biol Psychiatry.20106857858520673876
   PubMed Web of Science ®Google Scholar
• WalkerFO.Huntington's disease.Lancet.200736921822817240289
   PubMed Web of Science ®Google Scholar
• Munoz-SanjuanI.BatesGP.The importance of integrating basic and clinical research toward the development of new therapies for Huntington disease.J Clin Invest.201112147648321285520
   PubMed Web of Science ®Google Scholar
• CisbaniG.CicchettiF.An in vitro perspective on the molecular mechanisms underlying mutant huntingtin protein toxicity.Cell Death Dis.20123e38222932724
   PubMed Web of Science ®Google Scholar
• TrippierPC.Jansen LabbyK.HawkerDD.MatakaJJ.SilvermanRB.Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.J Med Chem.2013563121314723458846
   PubMed Web of Science ®Google Scholar
• RamockiMB.ZoghbiHY.Failure of neuronal homeostasis results in common neuropsychiatric phenotypes.Nature.200845591291818923513
   PubMed Web of Science ®Google Scholar
• Meyer-LindenbergA.Intermediate or brainless phenotypes for psychiatric research?Psychol Med.2010401057106220540175
   PubMed Web of Science ®Google Scholar
• VillanuevaR.Neurobiology of major depressive disorder.Neural Plast.2013201387327824222865
   PubMed Web of Science ®Google Scholar
• DumanRS.Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections.Dialogues Clin Neurosci.201416112724733968
   PubMed Web of Science ®Google Scholar
• LeuchterAF.CookIA.JinY.PhillipsB.The relationship between brain oscillatory activity and therapeutic effectiveness of transcranial magnetic stimulation in the treatment of major depressive disorder.Front Hum Neurosci.20137 37
   PubMed Web of Science ®Google Scholar
• PriceJL.DrevetsWC.Neurocircuitry of mood disorders.Neuropsychopharmacology.20103519235216
   Google Scholar
• LujanJL.ChaturvediA.MclntyreCC.Tracking the mechanisms of deep brain stimulation for neuropsychiatric disorders.Front Biosci.2008135892590418508630
   PubMed Web of Science ®Google Scholar
• DayerA.Serotonin-related pathways and developmental plasticity: relevance for psychiatric disorders.Dialogues Clin Neurosci.201416294124733969
   PubMed Web of Science ®Google Scholar
• HunterAM.LeuchterAF.MorganML.et alNeurophysiologic correlates of side effects in normal subjects randomized to venlafaxine or placebo.Neuropsychopharmacology.20053079279915637637
   PubMed Web of Science ®Google Scholar
• HunterAM.LeuchterAF.MorganML.CookIA.Changes in brain function (quantitative EEG cordance) during placebo lead-in and treatment outcomes in clinical trials for major depression.Am J Psychiatry.20061631426143216877657
   PubMed Web of Science ®Google Scholar
• HunterAM.KorbAS.CookIA.LeuchterAF.Rostral anterior cingulate activity in major depressive disorder state or trait marker of responsiveness to medication?J Neuropsychiatry Clin Neurosci.20132512613323686030
   PubMed Web of Science ®Google Scholar
• El-HageW.LemanS.CamusV.BelzungC.Mechanisms of antidepressant resistance.Front Pharmacol.20134 146
   PubMed Web of Science ®Google Scholar
• LeuchterAF.CookIA.HunterAM.KorbAS.A new paradigm for the prediction of antidepressant treatment response.Dialogues Clin Neurosci.20091143544620135901
   PubMedGoogle Scholar
• LeuchterAF.CookIA.MarangellLB.et alComparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study.Psychiatry Res.200916912413119712979
   PubMed Web of Science ®Google Scholar
• de GeusEJ.From genotype to EEG endophenotype: a route for postgenomic understanding of complex psychiatric disease?Genome Med.201026320828426
   PubMed Web of Science ®Google Scholar
• LeistedtSJ.LinkowskiP.Brain, networks, depression, and more.Eur Neuropsychopharmacol.201323552362
   Web of Science ®Google Scholar
• SmitDJ.StamCJ.PosthumaD.BoomsmaDl.de GeusEJ.Heritability of “small-world” networks in the brain: a graph theoretical analysis of resting-state EEG functional connectivity.Hum Brain Mapp.2008291368137818064590
   PubMed Web of Science ®Google Scholar
• LeuchterAF.CookIA.GilmerWS.et alEffectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.Psychiatry Res.200916913213819709754
   PubMed Web of Science ®Google Scholar
• losifescuDV.GreenwaldS.DevlinP.et alFrontal EEG predictors of treatment outcome in major depressive disorder.Eur Neuropsychopharmacol.20091977277719574030
   PubMed Web of Science ®Google Scholar
• BaresM.NovakT.KopecekM.BrunovskyM.StopkovaP.HöschlC.The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data.Eur Arch Psychiatry Clin Neurosci.2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• CookIA.LeuchterAF.MorganM.et alEarly changes in prefrontal activity characterize clinical responders to antidepressants.Neuropsychopharmacol.200227120131
   PubMed Web of Science ®Google Scholar
• CookIA.HunterAM.AbramsM.SiegmanB.LeuchterAF.Midline and right frontal brain function as a physiologic biomarker of remission in major depression.Psychiatry Res.200917415215719853417
   PubMed Web of Science ®Google Scholar
• BaresM.BrunovskyM.KopecekM.et alChanges in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study.J Psychiatr Res.2007131932516889798
   PubMedGoogle Scholar
• BaresM.BrunovskyM.KopecekM.et alEarly reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder.Eur Psychiatry.20082335035518450430
   PubMed Web of Science ®Google Scholar
• BaresM.BrunovskyM.NovakT.et alThe change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments.Eur Neuropsychopharmacol.20102045946620421161
   PubMed Web of Science ®Google Scholar
• BaskaranA.MilevR.McintyreRS.The neurobiology of the EEG biomarker as a predictor of treatment response in depression.Neuropharmacology.20126350751322569197
   PubMed Web of Science ®Google Scholar
• BaresM.BrunovskyM.NovakT.et alQEEG theta cordance in the prediction of treatment outcome to prefrontal repetitive transcranial magnetic stimulation or venlafaxine ER in patients with Major Depressive Disorder.Clin EEG Neurosci.2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• OzekesS.ErguzelT.SayarGH.TarhanN.Analysis of brain functional changes in high-frequency repetitive Transcranial Magnetic Stimulation in treatment-resistant depression.Clin EEG Neurosci.2014. [Epub ahead of print]
   Web of Science ®Google Scholar
• ArnsM.DrinkenburgWH.FitzgeraldPB.KenemansJL.Neurophysiological predictors of non-response to rTMS in depression.Brain Stimul.2012556957622410477
   PubMed Web of Science ®Google Scholar
• BroadwayJM.HoltzheimerPE.HilimireMR.et alFrontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study.Neuropsychopharmacology.2012371764177222414813
   PubMed Web of Science ®Google Scholar
• HunterAM.CookIA.GreenwaldSD.et alThe antidepressant treatment response index and treatment outcomes in a placebo-controlled trial of fluoxetine.J Clin Neurophysiol.20112847848221946361
   PubMed Web of Science ®Google Scholar
• LeuchterAF.CookIA.DeBrotaDJ.et alChanges in brain function during administration of venlafaxine or placebo to normal subjects.Clin EEG Neurosci.20083917518119044214
   PubMed Web of Science ®Google Scholar
• LlinásRR.RibaryU.JeanmonodD.KronbergE.MitraPP.Thalamocortical dysrhythmia: a neurological and neuropsychiatric syndrome characterized by magnetoencephalography.Proc Natl Acad Sci USA.199996152221522710611366
   PubMed Web of Science ®Google Scholar
• LlinásR.RibaryU.JeanmonodD.CancroetR.alThalamocortical dysrhythmia I. Functional and imaging aspects.Thal Rel Sys.20011237244
   Google Scholar
• LlinásR.UrbanoFJ.LeznikE.RamirezRR.van MarieHJF.Rhythmic and dysrhythmic thalamocortical dynamics: GABA systems and the edge effect.Trends Neurosci.20052832533315927689
   PubMed Web of Science ®Google Scholar
• Perez-ReyesE.LoryMolecular biology of T-type calcium channels.CNS Neurol Disord Drug Targets.2006560560917168745
   PubMed Web of Science ®Google Scholar
• SchulmanJJ.CancroR.LoweS.LuF.WaltonKD.LlinásRR.Imaging of thalamocortical dysrhythmia in neuropsychiatry.Front Hum Neurosci.2011511121283556
   PubMedGoogle Scholar
• MoncktonJE.McCormickDA.Neuromodulatory role of serotonin in the ferret thalamus.J Neurophysiol.2002872124213611929930
   PubMed Web of Science ®Google Scholar
• CeladaP.PuigMV.ArtigasF.Serotonin modulation of cortical neurons and networks.Front Integr Neurosci.201372523626526
   PubMedGoogle Scholar
• MaejimaT.MasseckOA.MarkMD.HerlitzeS.Modulation of firing and synaptic transmission of serotonergic neurons by intrinsic G proteincoupled receptors and ion channels.Front Integr Neurosci.201374023734105
   PubMedGoogle Scholar
• HughesSW.LörinczM.CopeDW.et alSynchronized oscillations at alpha and theta frequencies in the lateral geniculate nucleus.Neuron.20044225326815091341
   PubMed Web of Science ®Google Scholar
• CrunelliV.CopeDW.HughesSW.Thalamic T-type Ca2* channels and NREM sleep.Cell Calcium.20064017519016777223
   PubMed Web of Science ®Google Scholar
• HughesSW.CrunelliV.Thalamic mechanisms of EEG alpha rhythms and their pathological implications.Neuroscientist.20051135716061522
   PubMed Web of Science ®Google Scholar
• FugettaG.NohA.A neurophysiological insight into the potential link between transcranial magnetic stimulation, thalamocortical dysrhythmia and neuropsychiatric disorders.Exp Neurol.20124886393397
   Google Scholar
• De RidderD.Should rTMS for tinnitus be performed left-sided, ipsilaterally or contralaterally, and is it a treatment or merely investigational?Eur J Neurol.20101789189220236176
   PubMed Web of Science ®Google Scholar
• KopellB.GreenbergB.Anatomy and physiology of the basal ganglia: implications for DBS in psychiatry.Neurosci Behav Rev.200832408422
   PubMed Web of Science ®Google Scholar
• BianchiMT.Non-serotonin antidepressant actions: Direction channel modulation by SSRIs and the concept of single agent poly-pharmacy. MedHypoth.200870951956
   PubMed Web of Science ®Google Scholar
• ContrerasD.The role of T-channels in the generation of thalamocortical rhythms.CNS Neurol Disord Drug Targets.2006557158517168743
   PubMed Web of Science ®Google Scholar
• ShinHS.CheongEJ.ChoiS.LeeJ.NaHS.T-type Ca2+ channels as therapeutic targets in the nervous system.Curr Opin Pharmacol.20088334118203662
   PubMed Web of Science ®Google Scholar
• BruderGE.SedorukJP.StewartJW.McGrathPJ.QuitkinFM.TenkeCE.Electroencephalographs alpha measures predict therapeutic response to a selective serotonin reuptake inhibitor antidepressant pre- and post -treatment findings.Biol Psychiatry.2008631171117718061147
   PubMed Web of Science ®Google Scholar
• GalderisiS.MucciA.BucciP.MignoneML.MajM.Influence of moclobemide on cognitive functions of nine depressed patients: pilot trial with neurophysiological and neuropsychological indices.Neuropsychobiology.19963348548821375
   PubMed Web of Science ®Google Scholar
• KnottVJ.TelnerJI.LapierreYD.BrowneM.HornER.Quantitative EEG in the prediction of antidepressant response to imipramine.J Affect Disord.1996391751848856421
   PubMed Web of Science ®Google Scholar
• UlrichG.HaugHJ.StieglitzRD.FähndrichE.Are there distinct biochemical subtypes of depression? EEG characteristics of clinically defined on-drug responders and non-responders.J Affect Disord.1988151811852975689
   PubMed Web of Science ®Google Scholar
• WidgeAS.AveryDH.ZarkowskiP.Baseline and treatment-emergent EEG biomarkers of antidepressant medication response do not predict response to repetitive transcranial magnetic stimulation.Brain Stimul.2013692993123763894
   PubMed Web of Science ®Google Scholar
• HunterAM.LeuchterAF.CookIA.AbramsM.Brain functional changes (QEEG cordance) and worsening suicidal ideation and mood symptoms during antidepressant treatment.Acta Psychiatr Scand.201012246146920384600
   PubMed Web of Science ®Google Scholar
• HunterAM.MuthénBO.CookIA.LeuchterAF.Antidepressant response trajectories and quantitative electroencephalography (QEEG) biomarkers in major depressive disorder.J Psychiatr Res.201044909819631948
   PubMed Web of Science ®Google Scholar
• Wi'sniewskiGS.McAllister-WilliamsRH.JakitowiczJ.NowickiZ.MajkowiczM.TrzebiatowskaIA.Effects of antidepressant drugs on electroencephalography alpha power: importance of study duration.Biol Psychiatry.200864e5e618801473
   PubMedGoogle Scholar
• BuzsákiG.AnastassiouCA.KochC.The origin of extracellular fields and currents-EEG, ECoG, LFP and spikes.Nat Rev Neurosci.20121340742022595786
   PubMed Web of Science ®Google Scholar
• RosanovaM.CasaliA.BellinaV.RestaF.MariottiM.MassiminiM.Natural frequencies of human corticothalamic circuits.J Neurosci.2009297679768519535579
   PubMed Web of Science ®Google Scholar
• CookIA.HunterAM.KorbAS.LeuchterAF.Do prefrontal midline electrodes provide unique neurophysiologic information in Major Depressive Disorder?J Psychiatr Res.201453697524630467
   PubMed Web of Science ®Google Scholar
• KorbAS.CookIA.HunterAM.LeuchterAF.Brain electrical source differences between depressed subjects and healthy controls.Brain Topogr.20082113814618958615
   PubMed Web of Science ®Google Scholar
• HagmannP.ThiranJP.JonassonL.et alDTI mapping of human brain connectivity: statistical fibre tracking and virtual dissection.Neurolmage.200319545554
   PubMed Web of Science ®Google Scholar
• EckertU.MetzgerCD.BuchmannJE.et alPreferential networks of the mediodorsal nucleus and centromedian-parafascicular complex of the thalamus--a DTI tractography study.Hum Brain Mapp.2012332627263721932264
   PubMed Web of Science ®Google Scholar
• AnandA.LiY.WangY.LoweMJ.DzemidzicM.Resting state corticolimbic connectivity abnormalities in unmedicated bipolar disorder and unipolar depression.Psychiat Res Neuroim.2009171189198
   PubMed Web of Science ®Google Scholar
• OsobaA.HänggiJ.LiM.et alDisease severity is correlated to tract specific changes of fractional anisotropy in MD and CM thalamus-A DTI study in major depressive disorder.J Affect Disord.201314911612823489404
   PubMed Web of Science ®Google Scholar
• ArnsM.OlbrichS.Two EEG channels do not make a'quantitative EEG (QEEG)': a response to Widge, Avery and Zarkowski (2013).Brain Stimul.2014714614824269203
   PubMed Web of Science ®Google Scholar
• WangDH.Wong-LinK.Comodulation of dopamine and serotonin on prefrontal cortical rhythms: a theoretical study.Front Integr Neurosci.201375423935568
   PubMedGoogle Scholar
• HarveyBD.SiokCJ.KissT.et alNeurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.Neuropharmacology.201375193023831682
   PubMed Web of Science ®Google Scholar
• HiyoshiT.KambeD.KarasawaJ.ChakiS.Differential effects of NMDA receptor antagonists at lower and higher doses on basal gamma band oscillation power in rat cortical electroencephalograms.Neuropharmacology.20148538439624907590
   PubMed Web of Science ®Google Scholar
• BianchiMT.BotzolakisEJ.Targeting ligand-gated ion channels in neurology and psychiatry: is pharmacological promiscuity an obstacle or an opportunity?BMC Pharmacol.201010320196850
   PubMedGoogle Scholar
• HunterA.BordelonY.CookI.LeuchterA.QEEG measures in Huntington's Disease: a pilot study.PLoS Curr.2010 Oct 252RRN119221037796
   PubMedGoogle Scholar
• GiacomelloM.OliverosJC.NaranjoJR.CarafoliE.Neuronal Ca(2+) dyshomeostasis in Huntington disease.Prion.20137768423324594
   PubMed Web of Science ®Google Scholar
• KantorS.SzaboL.VargaJ.CuestaM.MortonAJ.Progressive sleep and electroencephalogram changes in mice carrying the Huntington's disease mutation.Brain.20131362147215823801737
   PubMed Web of Science ®Google Scholar
• FisherSP.BlackSW.SchwartzMD.et alLongitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease.Brain.20131362159217223801738
   PubMed Web of Science ®Google Scholar
• WardenD.TrivediMH.WisniewskiSR.et alPredictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.Am J Psychiatry.20071641189119717671281
   PubMed Web of Science ®Google Scholar
• OlfsonM.MarcusS.Tedeschi M: Continuity of antidepressant treatment for adults with depression in the United StatesAm J Psychiatry.200616310110816390896
   PubMed Web of Science ®Google Scholar
• Martins-de-SouzaD.Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder.Dialogues Clin Neurosci.201416637324733971
   PubMed Web of Science ®Google Scholar